Literature DB >> 20083062

Evaluation of myocarditis with delayed-enhancement computed tomography.

Kelly Axsom1, Fay Lin, Jonathan W Weinsaft, James K Min.   

Abstract

A healthy 19-year-old man with no history of substance abuse presented with 3 days of dyspnea and chest pressure relieved by leaning forward associated with nausea, emesis, and diarrhea. Cardiac computed tomography angiography (CCTA) showed normal coronary artery anatomy and no evidence of coronary artery plaque. The delayed-enhancement CCTA showed patchy epicardial and mid-myocardial enhancement of the wall and apex, consistent with myocardial inflammation. Delayed-enhancement cardiac magnetic resonance imaging (CMR) performed the following day confirmed patchy, diffuse epicardial hyperenhancement of the lateral wall, septum, and apex consistent with myocardial inflammation. Both CCTA and CMR supported the diagnosis of acute myocarditis. Delayed-enhancement CCTA is correlated with delayed-enhancement CMR in acute myocarditis by territory and extent and can show late hyperenhancement that can be transmural, subepicardial, or confined to small foci within a layer of the myocardium. Delayed-enhancement CCTA has potential utility for simultaneous evaluation of coronary arteries and myocardial inflammation in suspected myocarditis. Copyright (c) 2009 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20083062     DOI: 10.1016/j.jcct.2009.09.003

Source DB:  PubMed          Journal:  J Cardiovasc Comput Tomogr        ISSN: 1876-861X


  8 in total

1.  Acute inferolateral ST-elevation myopericarditis diagnosed by delayed enhancement cardiac computed tomography.

Authors:  Ricardo Krieger Azzolini; Fernando Arturo Effio Solis; Paulo Cury Rezende; Claudio Campi; Henrique Lane Staniak; Rodolfo Sharovsky; Alexandre Volney Villa; Paulo Andrade Lotufo; Márcio Sommer Bittencourt
Journal:  J Cardiol Cases       Date:  2011-02-24

2.  Infarct detection with a comprehensive cardiac CT protocol.

Authors:  Brian B Ghoshhajra; Pal Maurovich-Horvat; Tust Techasith; Hector M Medina; Daniel Verdini; Manavjot S Sidhu; Ron Blankstein; Thomas J Brady; Ricardo C Cury
Journal:  J Cardiovasc Comput Tomogr       Date:  2011-11-18

Review 3.  Delayed enhancement cardiac computed tomography for the assessment of myocardial infarction: from bench to bedside.

Authors:  Gaston A Rodriguez-Granillo
Journal:  Cardiovasc Diagn Ther       Date:  2017-04

Review 4.  Assessment of Left Ventricular Myocardial Diseases with Cardiac Computed Tomography.

Authors:  Sung Min Ko; Tae Hoon Kim; Eun Ju Chun; Jin Young Kim; Sung Ho Hwang
Journal:  Korean J Radiol       Date:  2019-03       Impact factor: 3.500

Review 5.  Echocardiography and Multimodality Cardiac Imaging in COVID-19 Patients.

Authors:  Alberto Cresti; Agata Barchitta; Andrea Barbieri; Ines Paola Monte; Giuseppe Trocino; Quirino Ciampi; Sofia Miceli; Licia Petrella; Emilija Jaric; Marco Solari; Cristina Basso; Mauro Pepi; Francesco Antonini-Canterin
Journal:  J Cardiovasc Echogr       Date:  2020-10-27

6.  Persistent Cardiac Magnetic Resonance Imaging Features of Myocarditis Detected Months After COVID-19 Infection.

Authors:  Basel Abdelazeem; Mariem Borcheni; Saed Alnaimat; Sagar Mallikethi-Reddy; Abdulbaset Sulaiman
Journal:  Cureus       Date:  2021-04-01

7.  Focal Myopericarditis as a Rare but Important Differential Diagnosis of Myocardial Infarction; a Case Series.

Authors:  Younes Nozari; Masih Tajdini; Mehdi Mehrani; Rosa Ghaderpanah
Journal:  Emerg (Tehran)       Date:  2016

Review 8.  Role of computed tomography in COVID-19.

Authors:  Gianluca Pontone; Stefano Scafuri; Maria Elisabetta Mancini; Cecilia Agalbato; Marco Guglielmo; Andrea Baggiano; Giuseppe Muscogiuri; Laura Fusini; Daniele Andreini; Saima Mushtaq; Edoardo Conte; Andrea Annoni; Alberto Formenti; Antonio Giulio Gennari; Andrea I Guaricci; Mark R Rabbat; Giulio Pompilio; Mauro Pepi; Alexia Rossi
Journal:  J Cardiovasc Comput Tomogr       Date:  2020-09-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.